leisure time -WSS

leisure time

author：entertainment 2025-09-28 21:05:31 - browse：89299

Scanned cerebellum of a mouse brain, affected by Niemann-Pick Type C, shown in pink and teal — biotech coverage from STAT — The cerebellum of a mouse brain affected by Niemann-Pick Type C. Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health

About a decade ago, Tatiana Bremova-Ertl’s graduate adviser was studying an obscure, 1950s-era French vertigo drug, probing its effects on people with balance disorders, when she thought of another, very sick group of patients.

A graduate student and medical resident at the German Center for Vertigo and Balance Disorders, in Munich, Bremova-Ertl often saw patients with Niemann-Pick Type C, a rare, genetic disease that slowly kills neurons.

NPC has a range of manifestations. When symptoms appear in early childhood, it is often fatal before adulthood. When it manifests later, it can be milder. But it’s always degenerative and leads to a cluster of challenges: cognitive decline, difficulty with speech and swallowing, enlarged liver, low muscle tone, and, notably, difficulty with balance and muscle control. Researchers and a fervent group of parents were working to develop medicines, but little had yet worked.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Readout LOUD podcast: ALS dilemma, first MASH drug, and more

WSS

How many hemophilia patients actually want gene therapy?

Anthos stroke drug appears safer than common blood thinner

Why scientists need input from humanists on sensitive research

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

David Sabatini, ex

Does good food count as health care? Study aims to find out

focus

leisure time

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Gain of function research would be limited under House proposal

Drug repurposing or repositioning? The language matters

Why depression after traumatic brain injury is distinct

FDA approval of Sarepta Duchenne genetic therapy gives me hope

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Affirmative action in medical school literally saved lives

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Virginia high school admissions case could be legal follow

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

focus

HHS secretary Becerra pressed on Change HealthCare cyberattack

How to save health care price transparency rules

Astellas still sees hope in its gene therapy after four deaths

FDA advisers back CAR

NYU radiologists take on the challenge of expensive MRI machines

HHS secretary Becerra pressed on Change HealthCare cyberattack

focus

knowledge

knowledge

explore